Literature DB >> 21834074

The risk of breast cancer in women with a BRCA1 mutation from North America and Poland.

Jan Lubinski1, Tomasz Huzarski, Tomasz Byrski, Henry T Lynch, Cezary Cybulski, Parviz Ghadirian, Malgorzata Stawicka, William D Foulkes, Ewa Kilar, Charmaine Kim-Sing, Susan L Neuhausen, Susan Armel, Dawna Gilchrist, Kevin Sweet, Jacek Gronwald, Andrea Eisen, Bohdan Gorski, Ping Sun, Steven A Narod.   

Abstract

Women with a BRCA1 mutation face a high lifetime risk of breast cancer. It is unknown to what extent environmental factors modify the inherent genetic risk. If women from different countries, but with similar mutations, experience different levels of cancer risk, nongenetic risk modifiers are likely to be present. Study subjects were a cohort of 1477 women with a BRCA1 mutation, from Canada (n = 358), the United States (n = 256) and Poland (n = 863). The women were followed for a mean of 4.3 years and 130 incident cases of breast cancer were recorded. Annual cancer incidence rates were calculated, and based on these, penetrance curves were constructed for women from North America and Poland. In a Cox proportional hazards model, residence in Poland, versus North America, was associated with an adjusted hazard ratio of 0.54 (95% CI 0.34-0.86; p = 0.01). The risk of breast cancer to age 70 was estimated to be 49% for women from Poland and 72% for women from North America. Among women with BRCA1 mutations, the risk of breast cancer in women who reside in Poland is less than that of women who reside in North America. The reasons for the difference are unknown, but this observation suggests that environmental factors or genetic modifiers are important in determining risk.
Copyright © 2011 UICC.

Entities:  

Mesh:

Year:  2011        PMID: 21834074      PMCID: PMC3334396          DOI: 10.1002/ijc.26369

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Steven A Narod; Marie-Pierre Dubé; Jan Klijn; Jan Lubinski; Henry T Lynch; Parviz Ghadirian; Diane Provencher; Ketil Heimdal; Pal Moller; Mark Robson; Kenneth Offit; Claudine Isaacs; Barbara Weber; Eitan Friedman; Ruth Gershoni-Baruch; Gad Rennert; Barbara Pasini; Theresa Wagner; Mary Daly; Judy E Garber; Susan L Neuhausen; Peter Ainsworth; Hakan Olsson; Gareth Evans; Michael Osborne; Fergus Couch; William D Foulkes; Ellen Warner; Charmaine Kim-Sing; Olufunmilayo Olopade; Nadine Tung; Howard M Saal; Jeffrey Weitzel; Sofia Merajver; Marion Gauthier-Villars; Helena Jernstrom; Ping Sun; Jean-Sebastien Brunet
Journal:  J Natl Cancer Inst       Date:  2002-12-04       Impact factor: 13.506

2.  Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies.

Authors:  A C Antoniou; P D P Pharoah; S Narod; H A Risch; J E Eyfjord; J L Hopper; H Olsson; O Johannsson; A Borg; B Pasini; P Radice; S Manoukian; D M Eccles; N Tang; E Olah; H Anton-Culver; E Warner; J Lubinski; J Gronwald; B Gorski; H Tulinius; S Thorlacius; H Eerola; H Nevanlinna; K Syrjäkoski; O-P Kallioniemi; D Thompson; C Evans; J Peto; F Lalloo; D G Evans; D F Easton
Journal:  J Med Genet       Date:  2005-07       Impact factor: 6.318

3.  Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group.

Authors:  Nadine Andrieu; Douglas F Easton; Jenny Chang-Claude; Matti A Rookus; Richard Brohet; Elisabeth Cardis; Antonis C Antoniou; Teresa Wagner; Jacques Simard; Gareth Evans; Susan Peock; Jean-Pierre Fricker; Catherine Nogues; Laura Van't Veer; Flora E Van Leeuwen; David E Goldgar
Journal:  J Clin Oncol       Date:  2006-06-26       Impact factor: 44.544

4.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

Authors:  A Antoniou; P D P Pharoah; S Narod; H A Risch; J E Eyfjord; J L Hopper; N Loman; H Olsson; O Johannsson; A Borg; B Pasini; P Radice; S Manoukian; D M Eccles; N Tang; E Olah; H Anton-Culver; E Warner; J Lubinski; J Gronwald; B Gorski; H Tulinius; S Thorlacius; H Eerola; H Nevanlinna; K Syrjäkoski; O-P Kallioniemi; D Thompson; C Evans; J Peto; F Lalloo; D G Evans; D F Easton
Journal:  Am J Hum Genet       Date:  2003-04-03       Impact factor: 11.025

5.  Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.

Authors:  Steven A Narod; Jan Lubinski; Parviz Ghadirian; Henry T Lynch; Pal Moller; William D Foulkes; Barry Rosen; Charmaine Kim-Sing; Claudine Isaacs; Susan Domchek; Susan Domcheck; Ping Sun
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

6.  Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Joanne Kotsopoulos; Jan Lubinski; Henry T Lynch; Susan L Neuhausen; Parviz Ghadirian; Claudine Isaacs; Barbara Weber; Charmaine Kim-Sing; William D Foulkes; Ruth Gershoni-Baruch; Peter Ainsworth; Eitan Friedman; Mary Daly; Judy E Garber; Beth Karlan; Olufunmilayo I Olopade; Nadine Tung; Howard M Saal; Andrea Eisen; Michael Osborne; Hakan Olsson; Dawna Gilchrist; Ping Sun; Steven A Narod
Journal:  Cancer Causes Control       Date:  2005-08       Impact factor: 2.506

7.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

Authors:  D Ford; D F Easton; M Stratton; S Narod; D Goldgar; P Devilee; D T Bishop; B Weber; G Lenoir; J Chang-Claude; H Sobol; M D Teare; J Struewing; A Arason; S Scherneck; J Peto; T R Rebbeck; P Tonin; S Neuhausen; R Barkardottir; J Eyfjord; H Lynch; B A Ponder; S A Gayther; M Zelada-Hedman
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

8.  Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

Authors:  Andrea Eisen; Jan Lubinski; Jan Klijn; Pal Moller; Henry T Lynch; Kenneth Offit; Barbara Weber; Tim Rebbeck; Susan L Neuhausen; Parviz Ghadirian; William D Foulkes; Ruth Gershoni-Baruch; Eitan Friedman; Gadi Rennert; Teresa Wagner; Claudine Isaacs; Charmaine Kim-Sing; Peter Ainsworth; Ping Sun; Steven A Narod
Journal:  J Clin Oncol       Date:  2005-10-20       Impact factor: 44.544

9.  A high proportion of founder BRCA1 mutations in Polish breast cancer families.

Authors:  Bohdan Górski; Anna Jakubowska; Tomasz Huzarski; Tomasz Byrski; Jacek Gronwald; Ewa Grzybowska; Andrzej Mackiewicz; Malgorzata Stawicka; Marek Bebenek; Dagmara Sorokin; Łucja Fiszer-Maliszewska; Olga Haus; Hanna Janiszewska; Stanisław Niepsuj; Stanisław Góźdź; Lech Zaremba; Michał Posmyk; Maria Płuzańska; Ewa Kilar; Dorota Czudowska; Bernard Waśko; Roman Miturski; Jerzy R Kowalczyk; Krzysztof Urbański; Marek Szwiec; Jan Koc; Bogusław Debniak; Andrzej Rozmiarek; Tadeusz Debniak; Cezary Cybulski; Elzbieta Kowalska; Aleksandra Tołoczko-Grabarek; Stanisław Zajaczek; Janusz Menkiszak; Krzysztof Medrek; Bartłomiej Masojć; Marek Mierzejewski; Steven Alexander Narod; Jan Lubiński
Journal:  Int J Cancer       Date:  2004-07-10       Impact factor: 7.396

10.  Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.

Authors:  Andrea Eisen; Jan Lubinski; Jacek Gronwald; Pal Moller; Henry T Lynch; Jan Klijn; Charmaine Kim-Sing; Susan L Neuhausen; Lucy Gilbert; Parviz Ghadirian; Siranoush Manoukian; Gad Rennert; Eitan Friedman; Claudine Isaacs; Eliot Rosen; Barry Rosen; Mary Daly; Ping Sun; Steven A Narod
Journal:  J Natl Cancer Inst       Date:  2008-09-23       Impact factor: 13.506

View more
  16 in total

1.  Earlier age of onset in BRCA carriers-anticipation or cohort effect?: A Countercurrents Series.

Authors:  S A Narod
Journal:  Curr Oncol       Date:  2011-12       Impact factor: 3.677

Review 2.  Modifiable Lifestyle Factors: Opportunities for (Hereditary) Breast Cancer Prevention - a Narrative Review.

Authors:  Jacqueline Lammert; Sabine Grill; Marion Kiechle
Journal:  Breast Care (Basel)       Date:  2018-04-20       Impact factor: 2.860

3.  A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriers.

Authors:  S A Narod; N Tung; J Lubinski; T Huzarski; M Robson; H T Lynch; S L Neuhausen; P Ghadirian; C Kim-Sing; P Sun; W D Foulkes
Journal:  Curr Oncol       Date:  2014-04       Impact factor: 3.677

Review 4.  Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic intervention.

Authors:  Nicole M Davis; Melissa Sokolosky; Kristin Stadelman; Steve L Abrams; Massimo Libra; Saverio Candido; Ferdinando Nicoletti; Jerry Polesel; Roberta Maestro; Antonino D'Assoro; Lyudmyla Drobot; Dariusz Rakus; Agnieszka Gizak; Piotr Laidler; Joanna Dulińska-Litewka; Joerg Basecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Giuseppe Montalto; Melchiorre Cervello; Timothy L Fitzgerald; Zoya Demidenko; Alberto M Martelli; Lucio Cocco; Linda S Steelman; James A McCubrey
Journal:  Oncotarget       Date:  2014-07-15

5.  Cumulative Small Effect Genetic Markers and the Risk of Colorectal Cancer in Poland, Estonia, Lithuania, and Latvia.

Authors:  Pablo Serrano-Fernandez; Dagmara Dymerska; Grzegorz Kurzawski; Róża Derkacz; Tatiana Sobieszczańska; Zbigniew Banaszkiewicz; Hanno Roomere; Eneli Oitmaa; Andres Metspalu; Ramūnas Janavičius; Pavel Elsakov; Mindaugas Razumas; Kestutis Petrulis; Arvīds Irmejs; Edvīns Miklaševičs; Rodney J Scott; Jan Lubiński
Journal:  Gastroenterol Res Pract       Date:  2015-05-26       Impact factor: 2.260

6.  Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients.

Authors:  Rumyana Ivanova Dodova; Atanaska Velichkova Mitkova; Daniela Rosenova Dacheva; Lina Basam Hadjo; Alexandrina Ivanova Vlahova; Margarita Stoyanova Taushanova -Hadjieva; Spartak Stoyanov Valev; Marija Mitko Caulevska; Stanislava Dimitrova Popova; Ivan Emilov Popov; Tihomir Iliichev Dikov; Theophil Angelov Sedloev; Atanas Stefanov Ionkov; Konstanta Velinova Timcheva; Svetlana Liubomirova Christova; Ivo Marinov Kremensky; Vanio Ivanov Mitev; Radka Petrova Kaneva
Journal:  BMC Cancer       Date:  2015-07-17       Impact factor: 4.430

Review 7.  Effects of age on the detection and management of breast cancer.

Authors:  Andrew McGuire; James A L Brown; Carmel Malone; Ray McLaughlin; Michael J Kerin
Journal:  Cancers (Basel)       Date:  2015-05-22       Impact factor: 6.639

Review 8.  Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO.

Authors:  Emanuele Mazzola; Amanda Blackford; Giovanni Parmigiani; Swati Biswas
Journal:  Cancer Inform       Date:  2015-05-10

9.  The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation.

Authors:  Pål Møller; Astrid Stormorken; Marit Muri Holmen; Anne Irene Hagen; Anita Vabø; Lovise Mæhle
Journal:  Breast Cancer Res Treat       Date:  2014-03-12       Impact factor: 4.872

10.  Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status.

Authors:  Martin P Nilsson; Linda Hartman; Ingrid Idvall; Ulf Kristoffersson; Oskar T Johannsson; Niklas Loman
Journal:  Breast Cancer Res Treat       Date:  2014-01-30       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.